EquityFlowCompanies › Helex

Helex

Biotech

Terapie geniche mirate per malattie renali genetiche con piattaforma di drug design 3D.

Funding history

DateRoundAmount
Oct 2025Seed
Helex raised $3.5M in a seed led by pi Ventures for pre-clinical development of its drug against ADPKD.
$3.5M

Investors

Bluehill.VCSOSVpi Ventures

Similar companies in Biotech

Explore funding flow on EquityFlow →